Checking in during my lunch break. It appears that CYTR's entire focus now is on Orphazame and Arimoclomol, without regard to anything Aldox, LADR, or ASAP SOON! Sadly, guess that's what the focus of the SHAM will be as well. BS IMO! Like you said, this news is doing nothing for CYTR's pps, and likely only to benefit CYTR "Employees" and maybe, perhaps, our "yet to be born grandkids"! lol!
GL 2 US & CYTR!